Acarix and Geo-Med: A Win-Win Partnership for Veterans' Cardiac Care

Acarix, a pioneer in acoustic-based cardiac diagnostic solutions, has announced a strategic partnership with Geo-Med, a Service-Disabled Veteran-Owned Small Business (SDVOSB) specializing in medical and surgical products for the Department of Veterans Affairs (VA) and Department of Defense (DoD). This collaboration aims to enhance the availability of advanced medical technologies to America's veterans, with a particular focus on the CADScor System, Acarix's innovative diagnostic tool for assessing coronary artery disease (CAD) at the point of care.

The partnership signifies Acarix's commitment to improving the quality of care available to veterans by leveraging Geo-Med's considerable capabilities and reach within the VA and DoD. Mike Locke, CEO of Geo-Med, expressed his enthusiasm for the collaboration, stating, "Our mission has always focused on delivering the best medical solutions to our servicemen and women. Partnering with Acarix aligns perfectly with our goal, leveraging their pioneering CADScor System to add exceptional value to our product offerings and ultimately to the healthcare of our veterans."

The CADScor System, known for its efficiency and accurate low-risk stratification in assessing CAD, will now be more readily accessible within federal medical facilities serving veterans. This increased availability will ensure critical advancements in medical technology are within reach for the men and women who have served the United States.



The CADScor System's non-invasive and radiation-free assessment contributes to cost savings and improved patient outcomes in several ways. By ruling out significant CAD early in the diagnostic pathway, the system helps reduce the need for more advanced and costly diagnostic procedures, such as computed tomography coronary angiography (CTCA) or invasive coronary angiography (ICA). This early rule-out allows for timely intervention and treatment for patients with positive results, potentially improving long-term patient outcomes.

The partnership between Acarix and Geo-Med has already led to the adoption of the CADScor System into the Standard Operating Procedure (SOP) of the Southeast Louisiana VA Healthcare System and the placement of initial orders at the Biloxi VA Medical Center. This demonstrates the potential for further expansion into additional VA facilities, increasing the overall impact of the partnership.

In conclusion, the partnership between Acarix and Geo-Med enhances the accessibility of advanced cardiac diagnostic tools for veterans by increasing availability, saving costs, improving risk stratification, ensuring equitable access, and facilitating expansion into additional VA facilities. This collaboration contributes to the overall improvement of the VA healthcare system's ability to provide high-quality care to veterans, ultimately leading to better patient outcomes and cost savings.